Date | HS Code | Product Description | Origin Country | Unit | Quantity | Total Value [USD] | Unit Price [USD] | Importer Name | Supplier Name |
---|---|---|---|---|---|---|---|---|---|
28/Jan/2019 | 30049099 | Clinical trial drug Cabotegravir 30 mg tablets , vial of 30 tablets; Cabotegravir 30 mg / tablet. Lot No. 172401848 , HSD: October 31, 2019.NSX: GSK GMS Ware - England. | United Kingdom | Bottle/Jar/Tube | 18.00 | 786.06 | 43.67 | View Importer | View Supplier |
28/Jan/2019 | 30049099 | Placebo for Cabotegravir tablets clinical trial study drug, vial of 30 tablets. No active ingredients. Number 172402378 , HSD 31.10.2019.NSX: GSK GMS Ware - UK. | United Kingdom | Bottle/Jar/Tube | 18.00 | 430.92 | 23.94 | View Importer | View Supplier |
28/Jan/2019 | 30049099 | GSK1265744 LA 400mg / 2ml clinical trial drug (Cabotegravir injectable suspension - 2ml suspension tube) No. 182411866 , HSD 30/06 / 2020.GSK - UK manufactured | United Kingdom | Tube | 400.00 | 24,451.60 | 61.13 | View Importer | View Supplier |